HY-078020 | Interleukin Related interleukin-related.com

Product Name :
HY-078020

Search keywords :
HY-078020

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Undisclosed

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hefei Industrial Pharmaceutical Co Ltd

Active Company_Name :
Hefei Amvite Pharmaceuticals Co Ltd

Active Indication_Name:
Chronic Urticaria

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fibronectin Antibody (YA762)
CD38 Antibody
LAMP2a Antibody: LAMP2a Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP2a. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts